US Edition
Published • loading... • Updated
NewAmsterdam Pharma (NASDAQ:NAMS) Director Sells $1,357,309.98 in Stock
Summary by insidertrades.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
NewAmsterdam Pharma (NASDAQ:NAMS) Director Sells $1,357,309.98 in Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) Director Louis Lange sold 44,619 shares of the business's stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $30.42, for a total value of $1,357,309.98. Following the transaction, the director owned 10,360 shares of the company's stock, valued at approximately $315,151.20. This trade represents a 81.16% decrease in their owner…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
